Antimonate(2-), bis[m-[(2R,3R)-2,3-di(hydroxy-kO)butanedioato(4-)-kO1:kO4]]di-, sodium (1:2) cas no:34521-09-0
Synonyms: Antimonate(2-),bis[m-[(2R,3R)-2,3-di(hydroxy-kO)butanedioato(4-)-kO1:kO4]]di-, disodium (9CI); Antimonate(2-), bis[m-[2,3-dihydroxybutanedioato(4-)-O1,O2:O3,O4]]di-,disodium, stereoisomer; Antimony sodium oxide tartrate (7CI); Diantimonyditartrate disodium (6CI); Butanedioic acid, 2,3-dihydroxy- [R-(R*,R*)]-, antimonycomplex; Antimony sodium oxide L-(+)-tartrate; Antimony sodium tartrate;Antimonyl sodium tartrate; Disodium bis(R,R-tartrato)diantimonate(2-); EmetoNa; Emetosodium; Sodium antimony tartrate; Sodium antimonyl tartrate; Stibnal;Stibunal
NameAntimonate(2-), bis[m-[(2R,3R)-2,3-di(hydroxy-kO)butanedioato(4-)-kO1:kO4]]di-, sodium (1:2)
CAS34521-09-0
SynonymsAntimonate(2-),bis[m-[(2R,3R)-2,3-di(hydroxy-kO)butanedioato(4-)-kO1:kO4]]di-, disodium (9CI); Antimonate(2-), bis[m-[2,3-dihydroxybutanedioato(4-)-O1,O2:O3,O4]]di-,disodium, stereoisomer; Antimony sodium oxide tartrate (7CI); Diantimonyditartrate disodium (6CI); Butanedioic acid, 2,3-dihydroxy- [R-(R*,R*)]-, antimonycomplex; Antimony sodium oxide L-(+)-tartrate; Antimony sodium tartrate;Antimonyl sodium tartrate; Disodium bis(R,R-tartrato)diantimonate(2-); EmetoNa; Emetosodium; Sodium antimony tartrate; Sodium antimonyl tartrate; Stibnal;Stibunal
EINECS(EC#)252-070-9
Molecular FormulaC8H4 O12 Sb2 . 2 Na
Molecular Weight581.608
Globally Harmonized System of Classification adn Labelling of Chemicals(GHS)
Hazardclass6.1
Safety
Poison by subcutaneous, intravenous, and intraperitoneal routes. Human toxic effects by intravenous route. Human mutation data reported. See also ANTIMONY COMPOUNDS. When heated to decomposition it emits toxic fumes of Sb.
Risk Statements 20/22-51/53
R20/22:Harmful by inhalation and if swallowed.
R51/53:Toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.
Safety Statements 61
S61:Avoid release to the environment. Refer to special instructions / safety data sheets.
RIDADR 1549
RTECS CC8050000
HazardClass 6.1
PackingGroup III
| 1. |
|
cyt-hmn:leu 2300 pmol/L/48H
|
|
MUREAV Mutation Research. 16 (1972),332. |
| 2. |
|
ivn-hmn TDLo:79 mg/kg/3D-I
|
|
TEARAI Terapevticheskii Archiv. Archives of Therapeutics. 34 (4)(1962),62. |
| 3. |
|
ipr-mus LD50:60 mg/kg
|
|
PSEBAA Proceedings of the Society for Experimental Biology and Medicine. 129 (1968),284. |
| 4. |
|
scu-mus LD50:48 mg/kg
|
|
PSEBAA Proceedings of the Society for Experimental Biology and Medicine. 129 (1968),284. |
| 5. |
|
ivn-mus LD50:25 mg/kg
|
|
MEIEDD Merck Index. 10 (1983),103. |
